Cargando…
Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
Background: Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder caused by an inherited genetic deficiency of ADAMTS13 and affects less than one per million individuals. Patients who are diagnosed with TTP during pregnancy are at increased risk of maternal and fetal complications...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737388/ https://www.ncbi.nlm.nih.gov/pubmed/36498688 http://dx.doi.org/10.3390/jcm11237115 |
_version_ | 1784847273802334208 |
---|---|
author | Skeith, Leslie Hurd, Kelle Chaturvedi, Shruti Chow, Lorraine Nicholas, Joshua Lee, Adrienne Young, Daniel Goodyear, Dawn Soucie, Jennifer Girard, Louis Dufour, Antoine Agbani, Ejaife O. |
author_facet | Skeith, Leslie Hurd, Kelle Chaturvedi, Shruti Chow, Lorraine Nicholas, Joshua Lee, Adrienne Young, Daniel Goodyear, Dawn Soucie, Jennifer Girard, Louis Dufour, Antoine Agbani, Ejaife O. |
author_sort | Skeith, Leslie |
collection | PubMed |
description | Background: Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder caused by an inherited genetic deficiency of ADAMTS13 and affects less than one per million individuals. Patients who are diagnosed with TTP during pregnancy are at increased risk of maternal and fetal complications including fetal demise. We present a case of a 32-year-old G3P0 (gravida 3, para 0) who presented at 20 weeks gestation with a new diagnosis of congenital TTP (cTTP) and fetal demise. Methods: We describe the pathophysiology of pregnancy complications in a patient with cTTP using platelet procoagulant membrane dynamics analysis and quantitative proteomic studies, compared to four pregnant patients with gestational hypertension, four pregnant patients with preeclampsia, and four healthy pregnant controls. Results: The cTTP patient had increased P-selectin, tissue factor expression, annexin-V binding on platelets and neutrophils, and localized thrombin generation, suggestive of hypercoagulability. Among 15 proteins that were upregulated, S100A8 and S100A9 were distinctly overexpressed. Conclusions: There is platelet-neutrophil activation and interaction, platelet hypercoagulability, and proinflammation in our case of cTTP with fetal demise. |
format | Online Article Text |
id | pubmed-9737388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97373882022-12-11 Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise Skeith, Leslie Hurd, Kelle Chaturvedi, Shruti Chow, Lorraine Nicholas, Joshua Lee, Adrienne Young, Daniel Goodyear, Dawn Soucie, Jennifer Girard, Louis Dufour, Antoine Agbani, Ejaife O. J Clin Med Case Report Background: Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder caused by an inherited genetic deficiency of ADAMTS13 and affects less than one per million individuals. Patients who are diagnosed with TTP during pregnancy are at increased risk of maternal and fetal complications including fetal demise. We present a case of a 32-year-old G3P0 (gravida 3, para 0) who presented at 20 weeks gestation with a new diagnosis of congenital TTP (cTTP) and fetal demise. Methods: We describe the pathophysiology of pregnancy complications in a patient with cTTP using platelet procoagulant membrane dynamics analysis and quantitative proteomic studies, compared to four pregnant patients with gestational hypertension, four pregnant patients with preeclampsia, and four healthy pregnant controls. Results: The cTTP patient had increased P-selectin, tissue factor expression, annexin-V binding on platelets and neutrophils, and localized thrombin generation, suggestive of hypercoagulability. Among 15 proteins that were upregulated, S100A8 and S100A9 were distinctly overexpressed. Conclusions: There is platelet-neutrophil activation and interaction, platelet hypercoagulability, and proinflammation in our case of cTTP with fetal demise. MDPI 2022-11-30 /pmc/articles/PMC9737388/ /pubmed/36498688 http://dx.doi.org/10.3390/jcm11237115 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Skeith, Leslie Hurd, Kelle Chaturvedi, Shruti Chow, Lorraine Nicholas, Joshua Lee, Adrienne Young, Daniel Goodyear, Dawn Soucie, Jennifer Girard, Louis Dufour, Antoine Agbani, Ejaife O. Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title_full | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title_fullStr | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title_full_unstemmed | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title_short | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise |
title_sort | hypercoagulability and inflammatory markers in a case of congenital thrombotic thrombocytopenic purpura complicated by fetal demise |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737388/ https://www.ncbi.nlm.nih.gov/pubmed/36498688 http://dx.doi.org/10.3390/jcm11237115 |
work_keys_str_mv | AT skeithleslie hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT hurdkelle hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT chaturvedishruti hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT chowlorraine hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT nicholasjoshua hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT leeadrienne hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT youngdaniel hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT goodyeardawn hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT souciejennifer hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT girardlouis hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT dufourantoine hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise AT agbaniejaifeo hypercoagulabilityandinflammatorymarkersinacaseofcongenitalthromboticthrombocytopenicpurpuracomplicatedbyfetaldemise |